ACAD

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ACADIA Pharmaceuticals (ACAD – Research Report) and Zimmer Biomet Holdings (ZBH – Research Report) with bullish sentiments. ACADIA Pharmaceuticals (ACAD) JMP Securities analyst Jason Butler reiterated a Buy rating on ACADIA Pharmaceuticals today and set a price target of $24.00. The company's shares closed last Wednesday at $15.93. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-acadia-pharmaceuticals-acad-and-zimmer-biomet-holdings-zbh?utm_source=advfn.com&utm_medium=referral